Open AccessAdjuvant effect of Chakshushya Rasayana with beta-blocker eye drops in the management of progressive glaucomatous optic neuropathy: An open-label randomized controlled trial
Author(s) -
K S Dhiman,
Veeranagouda S Adhoor,
Riju Agarwal,
Amit Mehta
Publication year - 2016
Publication title -
ayu
Language(s) - English
Resource type - Journals
eISSN - 0976-9382
pISSN - 0974-8520
DOI - 10.4103/ayu.ayu_30_16
Subject(s) - medicine , glaucoma , brimonidine , timolol , optic neuropathy , ophthalmology , randomized controlled trial , intraocular pressure , open angle glaucoma , randomization , optic nerve , surgery
Primary open angle glaucoma is an insidious and chronic vision-threatening eye ailment due to neuro-retino-optic nerve degeneration, which may be due to the raised intraocular pressure (IOP) or due to independent factors. Management of glaucoma is mainly concentrated on lowering IOP that requires lifetime topical medication, different ocular medicaments for lowering of IOP, and surgical interventions, but it has its own limitations to control the progression of glaucomatous optic neuropathy (GON), and this is the reason behind the use of alternative neuroprotective adjuvants.